| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | ABC20 ELISA Kit; ABCB1 ELISA Kit; ATP binding cassette, sub family B (MDR/TAP), member 1 ELISA Kit; ATP-binding cassette sub-family B member 1 ELISA Kit; CD243 ELISA Kit; CLCS ELISA Kit; Colchicin sensitivity ELISA Kit; Doxorubicin resistance ELISA Kit; GP170 ELISA Kit; MDR1 ELISA Kit; MDR1_HUMAN ELISA Kit; Multidrug resistance 1 ELISA Kit; Multidrug resistance protein 1 ELISA Kit; P glycoprotein 1 ELISA Kit; P gp ELISA Kit; P-glycoprotein 1 ELISA Kit; PGY1 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, ascitic fluid, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
permeability glycoprotein (ABCB1) is a biological molecule commonly studied in signal transduction research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P08183
Biological context
Researchers often monitor permeability glycoprotein in serum, plasma, ascitic fluid, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in permeability glycoprotein may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, permeability glycoprotein may also appear under names such as ABC20 and ABCB1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that permeability glycoprotein participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Clinical & Medical
JC Eichhorst,/,2023
Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38
B Nikolova,Anticancer Research,2020
Role of P-glycoprotein inhibitors in children with drug-resistant epilepsy
Elkhayat HA.et al,Acta Neurol Scand. ,2017
ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population
Fukunaga K.et al,BMC Genet.,2016
Expression levels of P-glycoprotein in peripheral blood CD8+ T lymphocytes from HIV-1-infected patients on antiretroviral therapy
Jiu-Cong Zhang et al,International Journal of Molecular Medicine,2014
Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes
Ma X et al,Biomaterials.,2013
Role of P-glycoprotein inhibitors in children with intractable epilepsy
Yasmin Ibrahim Galal,Master's Thesis,2010